Benefit of COVID-19 vaccination accounting for potential risk compensation | npj Vaccines
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants | Nature Communications
VERIFY: Why is absolute risk reduction in COVID-19 vaccines smaller than relative risk reduction? - YouTube
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity | Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity |The National Academies Press
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
The Daily Herald - Why Relative Risk Reduction, not Absolute Risk Reduction, is most often used in calculating vaccine efficacy
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant | Science
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
Muddled-up data misleads on COVID-19 vaccine efficacy - Australian Associated Press
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room - The Lancet Microbe
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
PolitiFact | Instagram post misleads on vaccine efficacy by conflating two different measures
